Sign in

NCT07742085Completed

Self-Management in Adults With Asthma or COPD

A Single-Assessor-Blinded Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 3 Aug 2026

Brief summary (registry, in English)

This study is a single-blind (evaluator-blind), parallel-group randomized controlled trial comparing two approaches to home-based pulmonary rehabilitation self-management training in individuals with chronic respiratory disease (asthma or COPD): brochure-based and video-animation-based. The topic is current and clinically relevant; the comparison of digital health literacy and patient education materials is a relatively understudied area in the literature. Sample size calculations were performed, the CONSORT 2010 guidelines were followed, and the statistical method (mixed-design ANOVA) is appropriate to the study question.

Status (registry)
Completed
Study type
Interventional
Enrollment
104 (actual)
First submitted
28 Jul 2026
Start date
28 Feb 2026
Primary completion date
1 Jun 2026
Lead sponsor
Mustafa Kemal University
Diseases
Asthma, COPD
NCT number
NCT07742085

What you commit to

  • Study type: Interventional
  • Participants enrolled: 104
  • From 28 Feb 2026 to the primary completion date, 1 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Clinically unstable respiratory condition or acute disease exacerbation Neuromuscular disease Unstable cardiovascular disease Musculoskeletal disorder that could limit participation in the exercise program Cognitive impairment or mental disorder that could interfere with communication or compliance with the study procedures

Who the study is looking for

  • Diagnosis of asthma according to the Global Initiative for Asthma (GINA) 2025 guidelines or chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 guidelines Clinically stable while receiving medical treatment For participants with asthma, forced expiratory volume in 1 second (FEV₁) greater than 70% of the predicted value Ability to understand the study procedures and provide written informed consent

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hatay Mustafa Kemal University
Coordinator of this site? Confirm its status
AntakyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.